ロード中...
Resolution of Cystic Enhancement to Add-On Tumor Treating Electric Fields for Recurrent Glioblastoma after Incomplete Response to Bevacizumab
The NovoTTF-100A device emits alternating tumor treating electric fields (TTFields) that interfere with cytokinesis and chromosome segregation during mitosis. Because it has a similar efficacy to cytotoxic chemotherapy, the device has been approved by the United States Food and Drug Administration f...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Karger Publishers
2014-04-01
|
| シリーズ: | Case Reports in Neurology |
| 主題: | |
| オンライン･アクセス: | http://www.karger.com/Article/FullText/362264 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|